Atypical antipsychotics as "mood stabilizers": A retrospective chart review

被引:8
作者
Savas, Haluk A. [1 ]
Yumru, Mehmet [1 ]
Kaya, M. Cemal [1 ]
Selek, Salih [1 ]
机构
[1] Gaziantep Univ, Fac Med, Dept Psychiat, Gaziantep, Turkey
关键词
atypical antipsychotics; bipolar disorder; maintenance therapy; mood stabilizers; BIPOLAR DISORDER; DOUBLE-BLIND; RISPERIDONE MONOTHERAPY; MANIC PATIENTS; PLACEBO; COMBINATION; OLANZAPINE; QUETIAPINE; EFFICACY; LITHIUM;
D O I
10.1016/j.pnpbp.2007.03.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Introduction and common usage of atypical antipsychotics in maintenance therapy for bipolar disorders is an innovative perspective. The aim of the present study was to compare the efficacy of atypical antipsychotics (AA) used either as monotherapy or in combination with a mood stabilizer (MS) in the maintenance treatment. Method: 55 patients treated with AA either alone or in combination with a MS for bipolar I disorder which were followed up for 6 months were retrospectively evaluated. Clinical status was evaluated with Bech Rafaelsen Mania Rating Scale (BRMRS), 24-item Hamilton Depression Scale (HAMD) and Clinical Global Impressions Scale (CGI). Results: Having similar demographic and clinical backgrounds, patients on with both treatment groups had significant clinical improvement. During the maintenance phase, numbers of total attacks were not significantly different between the two treatment groups. Conclusion: Our naturalistic, controlled retrospective observations suggest the potential use of atypical antipsychotics in the long-term management of bipolar I disorder. Larger and prospective studies are needed to determine the role of atypical antipsychotics more clearly in the maintenance treatment of bipolar disorder. To the best of our knowledge this is the first study comparing MS+AA with only AA treatment regimen. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1064 / 1067
页数:4
相关论文
共 23 条
[1]   Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study [J].
Altamura, AC ;
Salvadori, D ;
Madaro, D ;
Santini, A ;
Mundo, E .
JOURNAL OF AFFECTIVE DISORDERS, 2003, 76 (1-3) :267-271
[2]  
[Anonymous], 2004, DIAGN STAT MAN MENT, V4th
[3]   Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants [J].
Baldassano, CF ;
Marangell, LB ;
Gyulai, L ;
Ghaemi, SN ;
Joffe, H ;
Kim, DR ;
Sagduyu, K ;
Truman, CJ ;
Wisniewski, SR ;
Sachs, GS ;
Cohen, LS .
BIPOLAR DISORDERS, 2005, 7 (05) :465-470
[4]  
Gelenberg AJ, 1996, J CLIN PSYCHIAT, V57, P49
[5]  
GOHEN M, 2000, ARHC GEN PSYCHIAT, V57, P841
[6]   Effective maintenance treatment - breaking the cycle of bipolar disorder [J].
Goodwin, G ;
Vieta, E .
EUROPEAN PSYCHIATRY, 2005, 20 (5-6) :365-371
[7]   Atypical antipsychotics in the treatment of bipolar affective disorders [J].
Hilger, E ;
Barnas, C .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2002, 70 (05) :234-242
[8]   Rapid Antimanic effect of risperidone monotherapy: A 3-week multicenter, double-blind, placebo-controlled trial [J].
Hirschfeld, RMA ;
Keck, PE ;
Kramer, M ;
Karcher, K ;
Canuso, C ;
Eerdekens, M ;
Grossman, F .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (06) :1057-1065
[9]   LITHIUM PROPHYLAXIS OF MANIC-DEPRESSIVE DISORDER - DAILY LITHIUM DOSING SCHEDULE VERSUS EVERY 2ND DAY [J].
JENSEN, HV ;
PLENGE, P ;
MELLERUP, ET ;
DAVIDSEN, K ;
TOFTEGAARD, L ;
AGGERNAES, H ;
BJORUM, N .
ACTA PSYCHIATRICA SCANDINAVICA, 1995, 92 (01) :69-74
[10]   A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder [J].
Keck, Paul E., Jr. ;
Calabrese, Joseph R. ;
McQuade, Robert D. ;
Carson, William H. ;
Carlson, Berit X. ;
Rollin, Linda M. ;
Marcus, Ronald N. ;
Sanchez, Raymond .
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (04) :626-637